While downregulation of c-MYC and G2/M checkpoint genes explains the antiproliferative activity, downregulation of TGF-beta and WNT/Beta-catenin pathways suggest the suppression of cancer cells stemness and metastasis. The gene discussed is MYC; the disease is cancer.